| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.04. | A SPAC I Acquisition Corp.: NewGenIvf and A SPAC I Announce Closing of Business Combination | 122 | PR Newswire | NewGenIvf's shares and warrants are expected to begin trading on the Nasdaq Capital Market under the tickers "NIVF" and "NIVFW", respectively, on April 4, 2024
NEW YORK, April 3, 2024 /PRNewswire/... ► Artikel lesen | |
| 03.04. | NOVAGOLD RESOURCES INC.: NOVAGOLD Reports First Quarter 2024 Financial Results | 265 | GlobeNewswire (Europe) | Committed to Advancing Donlin Gold to Full Feasibility Study Extensive Engagement Reinforcing and Deepening Donlin Gold's Social License Strong Treasury of $118 Million in Cash and Term Deposits... ► Artikel lesen | |
| 03.04. | Ashland, Inc.: Ashland announces executive organization changes to personal care and specialty additives | 158 | GlobeNewswire (Europe) | WILMINGTON, Del., April 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), the global additives and specialty ingredients company today announced executive organization changes to its personal... ► Artikel lesen | |
| 03.04. | BioRestorative Therapies, Inc: BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants | 109 | GlobeNewswire (Europe) | - Company is not offering shares pursuant to the registration statement - MELVILLE, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company")... ► Artikel lesen | |
| 03.04. | NEO Battery Materials Ltd.: NEO Battery Materials Announces Appointment of Dr. Dongmok Whang as New Director | 216 | GlobeNewswire (Europe) | TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- (TSXV: NBM) (OTC: NBMFF) NEO Battery Materials Ltd. ("NEO" or the "Company"), a low-cost silicon anode materials developer that enables longer-running... ► Artikel lesen | |
| 03.04. | MacroGenics, Inc.: MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures | 202 | GlobeNewswire (Europe) | Early interim safety data from Phase 2 TAMARACK study, including comparison to retrospective analysis from Phase 1 study, as submitted in ASCO abstractCompany plans to provide updated interim data... ► Artikel lesen | |
| 03.04. | Ocwen Financial Corp.: Ocwen Financial Announces Intention to Rebrand as Onity Group | 93 | GlobeNewswire (Europe) | Name change proposal to be submitted for approval at upcoming Annual Meeting of Shareholders New name embodies the Company's transformation into a balanced and diversified business Ocwen subsidiary... ► Artikel lesen | |
| 03.04. | Intuitive Machines, Inc.: Intuitive Machines-led Moon RACER Team Awarded NASA Lunar Terrain Vehicle Contract to Support the Agency's Artemis Campaign | 420 | GlobeNewswire (Europe) | HOUSTON, April 03, 2024 (GLOBE NEWSWIRE) -- NASA has awarded Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) ("Intuitive Machines") ("Company") $30 million as a prime contractor to complete a Lunar... ► Artikel lesen | |
| 03.04. | Solid Biosciences Inc.: Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 234 | GlobeNewswire (Europe) | CHARLESTOWN, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases... ► Artikel lesen | |
| 03.04. | Sportsman's Warehouse Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results | 111 | GlobeNewswire (Europe) | WEST JORDAN, Utah, April 03, 2024 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's Warehouse" or the "Company") (Nasdaq: SPWH) today announced financial results for the fourteen... ► Artikel lesen | |
| 03.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 119 | GlobeNewswire (Europe) | CONSHOHOCKEN, Pa., April 03, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis... ► Artikel lesen | |
| 03.04. | QIAGEN N.V.: QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024 | 226 | GlobeNewswire (Europe) | Venlo, the Netherlands, April 03, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of new products to further enhance cancer research as well... ► Artikel lesen | |
| 03.04. | Zhibao Technology Inc. Announces Closing of Initial Public Offering | 123 | GlobeNewswire (Europe) | Shanghai, China, April 03, 2024 (GLOBE NEWSWIRE) -- Zhibao Technology Inc. (Nasdaq: "ZBAO" or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance... ► Artikel lesen | |
| 03.04. | Standard BioTools Inc.: Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan Platform for Translational Medicine Research | 170 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in human health - today... ► Artikel lesen | |
| 03.04. | Good resilience of SYNERGIE 2023 financial performance in a challenging economic context | 108 | GlobeNewswire (Europe) | Paris, April 3rd, 2024 GOOD RESILIENCE OF SYNERGIE 2023FINANCIAL PERFORMANCE IN A CHALLENGINGECONOMIC CONTEXT Revenue: €3.108.5... ► Artikel lesen | |
| 03.04. | IBEX Technologies Inc.: IBEX Shareholders Approve Sale of the Company | 162 | GlobeNewswire (Europe) | MONTRÉAL, Québec, April 03, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX Venture: IBT) is pleased to announce that at an annual and special meeting held today, IBEX... ► Artikel lesen | |
| 03.04. | Eupraxia Pharmaceuticals Inc.: Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024 | 83 | PR Newswire | Company's Listing Application Approved by Nasdaq
VICTORIA, BC, April 3, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage... ► Artikel lesen | |
| 03.04. | Blue Ridge Bankshares, Inc. Announces the Signing, Closing and Funding of Amended and Restated Definitive Purchase Agreements for $150 Million in a Private Placement of Common and Preferred Stock | 95 | PR Newswire | Capital expected to allow the bank to reposition business lines, support organic growth and further enhance capital levels of the core community bank
CHARLOTTESVILLE, Va., April 3, 2024 /PRNewswire/... ► Artikel lesen | |
| 03.04. | Opera Limited: Opera and Google Extend Search Agreement | 139 | PR Newswire | OSLO, Norway, April 3, 2024 /PRNewswire/ -- Opera Limited (NASDAQ: OPRA), one of the world's major browser developers and a leading internet consumer brand, announced that its current Google search... ► Artikel lesen | |
| 03.04. | Olin Corporation: Olin Among U.S. Epoxy Resin Producers Filing Trade Cases Against Five Countries | 440 | PR Newswire | CLAYTON, Mo., April 3, 2024 /PRNewswire/ -- Olin Corporation (NYSE: OLN) today announced the filing of antidumping and countervailing duty petitions against five countries related to certain epoxy... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| SUPER MICRO COMPUTER | 7.505 |
| BAYER | 6.267 |
| EVOTEC | 6.267 |
| NVIDIA | 5.319 |
| TUI | 3.630 |
| RENK GROUP | 3.219 |
| TESLA | 3.004 |
| RHEINMETALL | 2.852 |
| NEL | 2.800 |
| MICROSTRATEGY | 2.650 |
| VOLKSWAGEN | 1.306 |
| BYD | 1.215 |
| DEUTSCHE BANK | 1.135 |
| PLUG POWER | 1.078 |
| BASF | 1.023 |
| COMMERZBANK | 1.006 |
| PALANTIR TECHNOLOGIES | 975 |
| JINKOSOLAR | 934 |
| AMAZON | 927 |
| MERCEDES-BENZ | 910 |
| DEUTSCHE TELEKOM | 895 |
| ALLIANZ | 892 |
| INTEL | 887 |
| THYSSENKRUPP | 851 |
| HUGO BOSS | 839 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
